Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anxiety Therapy
New anxiety therapy study findings reported from College of Judea and Samaria
March 2nd, 2007
Data detailed in "Antidepressant-induced undesirable weight gain: prevention with rimonabant without interference with behavioral effectiveness" have been presented. According to recent research published in the European Journal of Pharmacology, "Antidepressant pharmacotherapy has dramatically improved the quality of life for many patients. However, prolonged use may induce weight gain, resulting in enhanced risk for treatment noncompliance." "Cannabinoid CB(1) receptor antagonists decrease food intake and body weight, but may also affect mood. We investigated in female Sabra mice first, whether acute treatment with the cannabinoid receptor antagonist rimonabant...
Source: Drug Week (2007-03-02)
|
